Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Dzau, VJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 234 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Glueck, SB; Dzau, VJ; Lee, R; Pratt, RE
      Challenges of comparative expression profiling studies of complex diseases: mouse models of myocardial hypertrophy - Focus on "Divergent transcriptional responses to independent genetic causes of cardiac hypertrophy"

      PHYSIOLOGICAL GENOMICS
    2. Ranade, K; Chang, MS; Ting, CT; Pei, D; Hsiao, CF; Olivier, M; Pesich, R; Hebert, J; Chen, YDI; Dzau, VJ; Curb, D; Olshen, R; Risch, N; Cox, DR; Botstein, D
      High-throughput genotyping with single nucleotide polymorphisms

      GENOME RESEARCH
    3. Braun-Dullaeus, RC; Mann, MJ; Seay, U; Zhang, LN; von der Leyen, HE; Morris, RE; Dzau, VJ
      Cell cycle protein expression in vascular smooth muscle cells in vitro andin vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    4. Mangi, AA; Dzau, VJ
      Gene therapy for human bypass grafts

      ANNALS OF MEDICINE
    5. Dzau, VJ
      Tissue angiotensin and pathobiology of vascular disease - A unifying hypothesis

      HYPERTENSION
    6. Daviet, L; Lehtonen, JYA; Hayashida, W; Dzau, VJ; Horiuchi, M
      Intracellular third loops in AT1 and AT2 receptors determine subtype specificity

      LIFE SCIENCES
    7. Ehsan, A; Mann, MJ; Dell'Acqua, G; Dzau, VJ
      Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide genetherapy

      JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
    8. Dzau, VJ; Mann, MJ; Ehsan, A; Griese, DP
      Gene therapy and genomic strategies for cardiovascular surgery: The emerging field of surgiomics

      JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
    9. Dempsey, AA; Dzau, VJ; Liew, CC
      Cardiovascular genomics: Estimating the total number of genes expressed inthe human cardiovascular system

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    10. Yet, SF; Tian, R; Layne, MD; Wang, ZY; Maemura, K; Solovyeva, M; Ith, B; Melo, LG; Zhang, LN; Ingwall, JS; Dzau, VJ; Lee, ME; Perrella, MA
      Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice

      CIRCULATION RESEARCH
    11. von der Leyen, HE; Dzau, VJ
      Therapeutic potential of nitric oxide synthase gene manipulation

      CIRCULATION
    12. Dzau, VJ; Bernstein, K; Celermajer, D; Cohen, J; Dahlof, B; Deanfield, J; Diex, J; Drexler, H; Ferrari, R; van Gilst, W; Hansson, L; Hornig, B; Husain, A; Johnston, C; Lazar, H; Pepine, C; Rabelink, T; Remme, W; Ruilope, L; Ruzicka, M; Schunkert, H; Swedberg, K; Unger, T; Vaughan, D; Weber, M
      The relevance of tissue angiotensin-converting enzyme: Manifestations in mechanistic and endpoint data

      AMERICAN JOURNAL OF CARDIOLOGY
    13. Ehsan, A; Mann, MJ; Dzau, VJ
      Experimental models of arteriovenous grafting

      VASCULAR DISEASE AND INJURY
    14. Akishita, M; Horiuchi, M; Yamada, H; Zhang, LN; Shirakami, G; Tamura, K; Ouchi, Y; Dzau, VJ
      Inflammation influences vascular remodeling through AT(2) receptor expression and signaling

      PHYSIOLOGICAL GENOMICS
    15. Morishita, R; Gibbons, GH; Tomita, N; Zhang, LN; Kaneda, Y; Ogihara, T; Dzau, VJ
      Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation - Evidence for tissue angiotensin-converting enzyme function

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    16. Tomita, N; Morishita, R; Tomita, S; Gibbons, GH; Zhang, L; Horiuchi, M; Kaneda, Y; Higaki, J; Ogihara, T; Dzau, VJ
      Transcription factor decoy for NF kappa B inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo

      GENE THERAPY
    17. Tamura, K; Chen, YQE; Chen, Q; Nyui, N; Horiuchi, M; Takasaki, I; Tamura, N; Pratt, RE; Dzau, VJ; Umemura, S
      Expression of renin-angiotensin system and extracellular matrix genes in cardiovascular cells and its regulation through AT1 receptor

      MOLECULAR AND CELLULAR BIOCHEMISTRY
    18. von der Leyen, HE; Dzau, VJ
      Therapeutic potential of nitric oxide synthase gene manipulation

      NITRIC OXIDE
    19. Tamura, K; Chen, YQE; Horiuchi, M; Chen, Q; Daviet, L; Yang, ZY; Daviet, L; Lopez-Ilasaca, M; Mu, H; Pratt, RE; Dzau, VJ
      LXR alpha functions as a cAMP-responsive transcriptional regulator of geneexpression

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    20. Mann, MJ; Dzau, VJ
      Therapeutic applications of transcription factor decoy oligonucleotides

      JOURNAL OF CLINICAL INVESTIGATION
    21. Tamura, K; Chen, YQE; Lopez-Ilasaca, M; Daviet, L; Tamura, N; Ishigami, T; Akishita, M; Takasaki, I; Tokita, Y; Pratt, RE; Horiuchi, M; Dzau, VJ; Umemura, S
      Molecular mechanism of fibronectin gene activation by cyclic stretch in vascular smooth muscle cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    22. Libby, P; Dzau, VJ
      In memoriam - Arthur Mu-En Lee

      CIRCULATION RESEARCH
    23. Alexander, RW; Dzau, VJ
      Vascular biology - The past 50 years

      CIRCULATION
    24. Akishita, M; Iwai, M; Wu, L; Zhang, LN; Ouchi, Y; Dzau, VJ; Horiuchi, M
      Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice

      CIRCULATION
    25. Morishita, R; Gibbons, GH; Kaneda, Y; Ogihara, T; Dzau, VJ
      Systemic administration of HVJ viral coat-liposome complex containing human insulin vector decreases glucose level in diabetic mouse: A model of genetherapy

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    26. Ehsan, A; Mann, MJ; Dzau, VJ
      Gene therapy for cardiovascular disease and vascular grafts

      GENE THERAPY
    27. Dzau, VJ; Austin, MJF; Brown, P; Cowley, A; Housman, D; Mulligan, R; Rosenberg, R
      Revolution and renaissance

      PHYSIOLOGICAL GENOMICS
    28. von der Leyen, HE; Braun-Dullaeus, R; Mann, MJ; Zhang, LN; Niebauer, J; Dzau, VJ
      A pressure-mediated nonviral method for efficient arterial gene and oligonucleotide transfer

      HUMAN GENE THERAPY
    29. Weir, MR; Dzau, VJ
      The renin-angiotensin-aldosterone system: A specific target for hypertension management

      AMERICAN JOURNAL OF HYPERTENSION
    30. Lehtonen, JYA; Daviet, L; Nahmias, C; Horiuchi, M; Dzau, VJ
      Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis

      MOLECULAR ENDOCRINOLOGY
    31. Yamada, H; Akishita, M; Ito, M; Tamura, K; Daviet, L; Lehtonen, JYA; Dzau, VJ; Horiuchi, M
      AT(2) receptor and vascular smooth muscle cell differentiation in vasculardevelopment

      HYPERTENSION
    32. Horiuchi, M; Akishita, M; Dzau, VJ
      Recent progress in angiotensin II type 2 receptor research in the cardiovascular system

      HYPERTENSION
    33. Pratt, RE; Dzau, VJ
      Genomics and hypertension - Concepts, potentials, and opportunities

      HYPERTENSION
    34. Horiuchi, M; Yamada, H; Akishita, M; Ito, M; Tamura, K; Dzau, VJ
      Interferon regulatory factors regulate interleukin-1 beta-converting enzyme expression and apoptosis in vascular smooth muscle cells

      HYPERTENSION
    35. Mann, MJ; Whittemore, AD; Donaldson, MC; Belkin, M; Conte, MS; Polak, JF; Orav, EJ; Ehsan, A; Dell'Acqua, G; Dzau, VJ
      Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial

      LANCET
    36. Poston, RS; Mann, MJ; Hoyt, EG; Ennen, M; Dzau, VJ; Robbins, RC
      Antisense oligodeoxynucleotides prevent acute cardiac allograft rejection via a novel, nontoxic, highly efficient transfection method

      TRANSPLANTATION
    37. Mann, MJ; Gibbons, GH; Hutchinson, H; Poston, RS; Hoyt, EG; Robbins, RC; Dzau, VJ
      Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    38. Braun-Dullaeus, RC; Mann, MJ; Ziegler, A; von der Leyen, HE; Dzau, VJ
      A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy

      JOURNAL OF CLINICAL INVESTIGATION
    39. Akishita, M; Ito, M; Lehtonen, YA; Daviet, L; Dzau, VJ; Horiuchi, M
      Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth

      JOURNAL OF CLINICAL INVESTIGATION
    40. Lehtonen, JYA; Horiuchi, M; Daviet, L; Akishita, M; Dzau, VJ
      Activation of the de novo biosynthesis of sphingolipids mediates angiotensin II type 2 receptor-induced apoptosis

      JOURNAL OF BIOLOGICAL CHEMISTRY
    41. Daviet, L; Lehtonen, JYA; Tamura, K; Griese, DP; Horiuchi, M; Dzau, VJ
      Cloning and characterization of ATRAP, a novel protein that interacts withthe angiotensin II type 1 receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    42. Tomita, S; Tomita, N; Yamada, T; Zhang, LN; Kaneda, Y; Morishita, R; Ogihara, T; Dzau, VJ; Horiuchi, M
      Transcription factor decoy to study the molecular mechanism of negative regulation of renin gene expression in the liver in vivo

      CIRCULATION RESEARCH
    43. Horiuchi, M; Hayashida, W; Akishita, M; Tamura, K; Daviet, L; Lehtonen, JYA; Dzau, VJ
      Stimulation of different subtypes of angiotensin II receptors, AT(1) and AT(2) receptors, regulates STAT activation by negative crosstalk

      CIRCULATION RESEARCH
    44. Ing, DJ; Zang, J; Dzau, VJ; Webster, KA; Bishopric, NH
      Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x

      CIRCULATION RESEARCH
    45. Akishita, M; Yamada, H; Dzau, VJ; Horiuchi, M
      Increased vasoconstrictor response of the mouse lacking angiotensin II type 2 receptor

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    46. Brown, MD; Halpert, A; McKean, S; Sussman, A; Dzau, VJ
      Assessing the value of hospitalists to academic health centers: Brigham and Women's Hospital and Harvard Medical School

      AMERICAN JOURNAL OF MEDICINE
    47. DZAU VJ
      HABER,EDGAR - 1932-1997 - IN-MEMORIAM

      Proceedings of the Association of American Physicians
    48. DZAU VJ
      PRESENTATION OF THE 1998 KOBER-MEDAL TO BRAUNWALD,EUGENE

      Proceedings of the Association of American Physicians
    49. LIN DY; PRATT RE; KAHN CR; DZAU VJ
      THE ROLE OF INSULIN-RECEPTOR IN VASCULAR LESION FORMATION TRANSFER APPROACH

      Journal of investigative medicine
    50. POSTON RS; TRAN KP; MANN MJ; HOYT EG; DZAU VJ; ROBBINS RC
      PREVENTION OF ISCHEMICALLY INDUCED NEOINTIMAL HYPERPLASIA USING EX-VIVO ANTISENSE OLIGODEOXYNUCLEOTIDES

      The Journal of heart and lung transplantation
    51. Horiuchi, M; Akishita, M; Dzau, VJ
      Molecular and cellular mechanism of angiotensin II-mediated apoptosis

      ENDOCRINE RESEARCH
    52. SAYEEDSHAH U; MANN MJ; GRACHEV S; REUL R; FERZOCO SJ; LAURENCE R; DZAU VJ; COHN LH
      NONVIRAL GENE-TRANSFER IN PORCINE MYOCARDIUM ENHANCED BY TRANSMYOCARDIAL LASER REVASCULARIZATION

      Journal of the American College of Cardiology
    53. TOMITA N; HORIUCHI M; TOMITA S; GIBBONS GH; KIM JYS; BARAN D; DZAU VJ
      AN OLIGONUCLEOTIDE DECOY FOR TRANSCRIPTION FACTOR E2F INHIBITS MESANGIAL CELL-PROLIFERATION IN-VITRO

      American journal of physiology. Renal, fluid and electrolyte physiology
    54. LEHTONEN JYA; HAYASHIDA W; HORIUCHI M; DZAU VJ
      ANGIOTENSIN-II RECECEPTOR SUBTYPE-SPECIFIC EFFECTS ARE MEDIATED BY INTRACELLULAR 3RD LOOPS - CHIMERIC RECEPTOR APPROACH

      Journal of hypertension
    55. AKISHITA M; HORIUCHI M; YAMADA H; DZAU VJ
      FETAL VASCULAR SMOOTH-MUSCLE CELLS DERIVED FROM ANGIOTENSIN-II TYPE-2RECEPTOR KNOCKOUT MOUSE EXHIBIT LIGAND-INDEPENDENT GROWTH ENHANCEMENT

      Journal of hypertension
    56. LEHTONEN JYA; LAURENT D; HORIUCHI M; DZAU VJ
      CERAMIDE AS A 2ND-MESSENGER FOR ANGIOTENSIN-II TYPE-2 RECEPTOR-MEDIATED APOPTOSIS

      Journal of hypertension
    57. DZAU VJ
      MECHANISM OF PROTECTIVE EFFECTS OF ACE-INHIBITION ON CORONARY-ARTERY DISEASE

      European heart journal
    58. CHEN YQE; HORIUCHI M; DZAU VJ
      CLONING AND IDENTIFICATION OF A NOVEL REPRESSOR TRANSCRIPTIONAL FACTOR INHIBITING RENIN GENE-EXPRESSION

      Hypertension
    59. DZAU VJ; RE RN
      HABER,EDGAR,E. 1932-1997 - IN-MEMORIAM

      Hypertension
    60. YAMADA T; AKISHITA M; POLLMAN MJ; GIBBONS GH; DZAU VJ; HORIUCHI M
      ANGIOTENSIN-II TYPE-2 RECEPTOR MEDIATES VASCULAR SMOOTH-MUSCLE CELL APOPTOSIS AND ANTAGONIZES ANGIOTENSIN-II TYPE-1 RECEPTOR ACTION - AN IN-VITRO GENE-TRANSFER STUDY

      Life sciences (1973)
    61. MASAKI H; KURIHARA T; YAMAKI A; INOMATA N; NOZAWA Y; MORI Y; MURASAWA S; KIZIMA K; MARUYAMA K; HORIUCHI M; DZAU VJ; TAKAHASHI H; IWASAKA T; INADA M; MATSUBARA H
      CARDIAC-SPECIFIC OVEREXPRESSION OF ANGIOTENSIN-II AT2 RECEPTOR CAUSESATTENUATED RESPONSE TO AT1 RECEPTOR-MEDIATED PRESSOR AND CHRONOTROPICEFFECTS

      The Journal of clinical investigation
    62. DZAU VJ; HORIUCHI M
      VASCULAR REMODELING - THE EMERGING PARADIGM OF PROGRAMMED CELL-DEATH (APOPTOSIS) - THE FRANCIS-B-PARKER-LECTURESHIP

      Chest
    63. MANN MJ; WHITTEMORE AD; DONALDSON MC; BELKIN MA; CONTE MS; ORAV J; POLAK JF; DZAU VJ
      THE PREVENT TRIAL OF VEIN GRAFT GENETIC-ENGINEERING - PRELIMINARY MOLECULAR AND CLINICAL FINDINGS

      Circulation
    64. AKISHITA M; HORIUCHI M; ITO M; DZAU VJ
      ANGIOTENSIN-II TYPE-2 RECEPTOR SETS THE LEVEL OF ERK ACTIVITY AND INFLUENCES FETAL VASCULAR GROWTH

      Circulation
    65. CHEN YQE; HORIUCHI M; DZAU VJ
      CLONING AND CHARACTERIZATION OF A NOVEL TRANSCRIPTIONAL FACTOR REPRESSING RENIN GENE-EXPRESSION

      Circulation
    66. BRAUNDULLAEUS RC; MANN MJ; VONDERLEYEN HE; DZAU VJ
      ROLE OF THE CYCLIN-DEPENDENT KINASE INHIBITOR P27(KIP1)IN MEDIATING VASCULAR SMOOTH-MUSCLE CELL HYPERTROPHY

      Circulation
    67. BRAUNDULLAEUS RC; MANN MJ; VONDERLEYEN HE; DZAU VJ
      CELL-CYCLE DEPENDENT MODULATION OF VCAM-1 EXPRESSION IN VASCULAR SMOOTH-MUSCLE CELLS IS TRANSCRIPTIONALLY REGULATED THROUGH IRF-1

      Circulation
    68. DAVIET L; HORIUCHI M; HAYASHIDA W; LEHTONEN JYA; BISHOPRIC NH; DZAU VJ
      ANTAGONISTIC ACTIONS OF TYPE-1 AND TYPE-2 ANGIOTENSIN-II RECEPTORS ONRAT CARDIOMYOCYTE APOPTOSIS

      Circulation
    69. LEHTONEN JYA; DAVIET L; HORIUCHI M; DZAU VJ
      STRUCTURE-FUNCTION ANALYSIS OF ANGIOTENSIN-II TYPE-2 RECEPTOR 3RD INTRACELLULAR LOOP

      Circulation
    70. ZANG J; ING D; DZAU VJ; WEBSTER KA; BISHOPRIC NH
      NITRIC-OXIDE ACTIVATIONS OF CARDIOMYOCYTE APOPTOSIS, MAPK ERK AND JUNKINASES EXHIBIT DIFFERENTIAL DOSE-DEPENDENCE AND CGMP SENSITIVITY/

      Circulation
    71. DELLACQUA G; MANN MJ; DZAU VJ
      P53 ALTERNATIVE SPLICING IN RAT CARDIOMYOCYTES

      Circulation
    72. DAVIET L; LEHTONEN JYA; HORIUCHI M; DZAU VJ
      ATRAP, A NOVEL PROTEIN THAT INTERACTS WITH THE C-TERMINAL CYTOPLASMICDOMAIN OF THE ANGIOTENSIN-II TYPE-1 RECEPTOR

      Circulation
    73. BRAUNDULLAEUS RC; MANN MJ; DZAU VJ
      CELL-CYCLE PROGRESSION - NEW THERAPEUTIC TARGET FOR VASCULAR PROLIFERATIVE DISEASE

      Circulation
    74. MORISHITA R; GIBBONS GH; HORIUCHI M; KANEDA Y; OGIHARA T; DZAU VJ
      ROLE OF AP-1 COMPLEX IN ANGIOTENSIN II-MEDIATED TRANSFORMING-GROWTH-FACTOR-BETA EXPRESSION AND GROWTH OF SMOOTH-MUSCLE CELLS - USING DECOY APPROACH AGAINST AP-1 BINDING-SITE

      Biochemical and biophysical research communications
    75. BRAUNDULLAEUS RC; VONDERLEYEN HE; MANN MJ; ZHANG L; MORRIS RE; DZAU VJ
      LOSS OF P27(KIP1) AND INDUCTION OF CDK1 IN THE RAT CAROTID-ARTERY FOLLOWING BALLOON CATHETER INJURY - IN-VIVO AND IN-VITRO INFLUENCE OF RAPAMYCIN

      The FASEB journal
    76. KOIKE G; JACOB HJ; COWLEY AW; DZAU VJ; FANESTIL D; GRIGOR MR; HARRAP SB; HARRIS EJ; KRIEGER EM; KRIEGER JE; LANDER ES; PRINTZ MP; PROVOOST A; ROMAN RJ; SAMANI NJ; SASSARD J; SCHORK NJ; VINCENT M
      THE COMPREHENSIVE TOTAL GENOME SCAN MAP GENES RESPONSIBLE FOR HIGH BLOOD-PRESSURE IN THE RAT

      The FASEB journal
    77. HEIN L; MEINEL L; PRATT RE; DZAU VJ; KOBILKA BK
      INTRACELLULAR TRAFFICKING OF ANGIOTENSIN-II AND ITS AT(1) AND AT(2) RECEPTORS - EVIDENCE FOR SELECTIVE SORTING OF RECEPTOR AND LIGAND

      Molecular endocrinology
    78. KATSUYA T; HORIUCHI M; MINAMI S; KOIKE G; SANTORO NF; HSUEH AJW; DZAU VJ
      GENOMIC ORGANIZATION AND POLYMORPHISM OF HUMAN ANGIOTENSIN-II TYPE-2 RECEPTOR - NO EVIDENCE FOR ITS GENE MUTATION IN 2 FAMILIES OF HUMAN PREMATURE OVARIAN FAILURE SYNDROME

      Molecular and cellular endocrinology
    79. MANN MJ; MORISHITA R; GIBBONS GH; VONDERLEYEN HE; DZAU VJ
      DNA TRANSFER INTO VASCULAR SMOOTH-MUSCLE USING FUSIGENIC SENDAI VIRUS(HJV)-LIPOSOMES

      Molecular and cellular biochemistry
    80. MANN MJ; DZAU VJ
      GENETIC MANIPULATION OF VEIN GRAFTS

      Current opinion in cardiology
    81. DZAU VJ
      ANGIOTENSIN-II RECEPTOR ANTAGONISTS - CURRENT STATE AND FUTURE PERSPECTIVE - SATELLITE SYMPOSIUM TO THE 16TH SCIENTIFIC MEETING OF THE INTERNATIONAL-SOCIETY-OF-HYPERTENSION, 22 JUNE 1996, GLASGOW, UK - CONCLUDING REMARKS

      Journal of hypertension
    82. YAMADA H; HORIUCHI M; AKISHITA M; DZAU VJ
      REGULATION OF VASCULAR DEVELOPMENT AND DIFFERENTIATION BY ANGIOTENSIN-II TYPE-2 RECEPTOR

      Hypertension
    83. LEHTONEN JYA; HAYASHIDA W; HORIUCHI M; DZAU VJ
      ANGIOTENSIN-II RECEPTOR SUBTYPE-SPECIFIC EFFECTS ARE MEDIATED BY INTRACELLULAR 3RD-LOOPS

      Hypertension
    84. COOKE JP; DZAU VJ
      NITRIC-OXIDE SYNTHASE - ROLE IN THE GENESIS OF VASCULAR-DISEASE

      Annual review of medicine
    85. HEIN L; STEVENS ME; BARSH GS; PRATT RE; KOBILKA BK; DZAU VJ
      OVEREXPRESSION OF ANGIOTENSIN AT(1) RECEPTOR TRANSGENE IN THE MOUSE MYOCARDIUM PRODUCES A LETHAL PHENOTYPE ASSOCIATED WITH MYOCYTE HYPERPLASIA AND HEART-BLOCK

      Proceedings of the National Academy of Sciences of the United Statesof America
    86. AOKI M; MORISHITA R; MURAISHI A; MORIGUCHI A; SUGIMOTO T; MAEDA K; DZAU VJ; KANEDA Y; HIGAKI J; OGIHARA T
      EFFICIENT IN-VIVO GENE-TRANSFER INTO THE HEART IN THE RAT MYOCARDIAL-INFARCTION MODEL USING THE HVJ (HEMAGGLUTINATING VIRUS OF JAPAN) - LIPOSOME METHOD

      Journal of Molecular and Cellular Cardiology
    87. MANN MJ; GIBBONS GH; TSAO PS; VONDERLEYEN HE; COOKE JP; BUITRAGO R; KERNOFF R; DZAU VJ
      CELL-CYCLE INHIBITION PRESERVES ENDOTHELIAL FUNCTION IN GENETICALLY-ENGINEERED RABBIT VEIN GRAFTS

      The Journal of clinical investigation
    88. HORIUCHI M; HAYASHIDA W; KAMBE T; YAMADA T; DZAU VJ
      ANGIOTENSIN TYPE-2 RECEPTOR DEPHOSPHORYLATES BCL-2 BY ACTIVATING MITOGEN-ACTIVATED PROTEIN-KINASE PHOSPHATASE-1 AND INDUCES APOPTOSIS

      The Journal of biological chemistry
    89. HORIUCHI M; YAMADA T; HAYASHIDA W; DZAU VJ
      INTERFERON REGULATORY FACTOR-I UP-REGULATES ANGIOTENSIN-II TYPE-2 RECEPTOR AND INDUCES APOPTOSIS

      The Journal of biological chemistry
    90. MANN MJ; WHITTEMORE AD; DONALDSON MC; BELKIN MA; ORAV EJ; POLAK J; DZAU VJ
      PRELIMINARY CLINICAL-EXPERIENCE WITH GENETIC-ENGINEERING OF HUMAN VEIN GRAFTS - EVIDENCE FOR TARGET GENE INHIBITION

      Circulation
    91. BRAUNDULLAEUS RC; MANN MJ; VONDERLEYEN HE; MORRIS RE; DZAU VJ
      CELL-CYCLE PROTEIN EXPRESSION IN PROLIFERATING VASCULAR SMOOTH-MUSCLECELLS IS TRANSLATIONALLY REGULATED THROUGH MTOR AND P70S6 KINASE

      Circulation
    92. BRAUNDULLAEUS RC; MANN MJ; VONDERLEYEN HE; SHERWOOD SW; DZAU VJ
      EVIDENCE FOR CELL-CYCLE DEPENDENT PHENOTYPIC MODULATION OF VASCULAR SMOOTH-MUSCLE CELLS

      Circulation
    93. LEHTONEN JY; HAYASHIDA W; HORIUCHI M; DZAU VJ
      ANGIOTENSIN-II RECEPTOR SUBTYPE-SPECIFIC EFFECTS ARE MEDIATED BY INTRACELLULAR 3RD-LOOPS - CHIMERIC RECEPTOR APPROACH

      Circulation
    94. AKISHITA A; HORIUCHI M; YAMADA H; ZHANG LN; DZAU VJ
      ACCENTUATED VASCULAR PROLIFERATION AND ALTERED REMODELING AFTER INJURY IN MICE LACKING ANGIOTENSIN-II TYPE-2 RECEPTOR

      Circulation
    95. LEHTONEN JY; HORIUCHI M; DZAU VJ
      CERAMIDE AS A 2ND-MESSENGER FOR ANGIOTENSIN-II TYPE-2 RECEPTOR-MEDIATED APOPTOSIS

      Circulation
    96. YAMADA H; HORIUCHI M; AKISHITA M; DZAU VJ
      INTERFERON REGULATORY FACTOR-I UP-REGULATES INTERLEUKIN-1-BETA CONVERTING-ENZYME AND INDUCES APOPTOSIS IN VASCULAR SMOOTH-MUSCLE CELLS

      Circulation
    97. COOKE JP; DZAU VJ
      DERANGEMENTS OF THE NITRIC-OXIDE SYNTHASE PATHWAY, L-ARGININE, AND CARDIOVASCULAR-DISEASES

      Circulation
    98. DZAU VJ
      A SYMPOSIUM - NEW APPROACHES TO CARDIOVASCULAR THERAPY - INTRODUCTION

      The American journal of cardiology
    99. DZAU VJ; GIBBONS GH; MANN M; BRAUNDULLAEUS R
      FUTURE HORIZONS IN CARDIOVASCULAR MOLECULAR THERAPEUTICS

      The American journal of cardiology
    100. DZAU VJ; GERSH BJ; GANZ P; KATZ AM; MASSIE B
      NEW APPROACHES TO CARDIOVASCULAR THERAPY - PANEL DISCUSSION

      The American journal of cardiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 05:33:37